770308000: Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Fluticasone + Salmeterol\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)

\Medicinal product\Product manufactured as pulmonary dose form\Product containing salmeterol in pulmonary dose form (medicinal product form)\Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Product manufactured as pulmonary dose form\Product containing fluticasone in pulmonary dose form (medicinal product form)\Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor agonist\Product containing beta adrenergic receptor agonist\Product containing beta-2 adrenergic receptor agonist\Product containing salmeterol\Product containing salmeterol in pulmonary dose form (medicinal product form)\Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor agonist\Product containing beta adrenergic receptor agonist\Product containing beta-2 adrenergic receptor agonist\Product containing salmeterol\Product containing fluticasone and salmeterol\Fluticasone + Salmeterol\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor agonist\Product containing beta adrenergic receptor agonist\Product containing beta-2 adrenergic receptor agonist\Product containing salmeterol\Product containing fluticasone and salmeterol\Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing androstane\Product containing fluticasone\Product containing fluticasone in pulmonary dose form (medicinal product form)\Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing androstane\Product containing fluticasone\Product containing fluticasone and salmeterol\Fluticasone + Salmeterol\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing androstane\Product containing fluticasone\Product containing fluticasone and salmeterol\Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing corticosteroid and/or corticosteroid derivative (product)\Product containing fluorinated corticosteroid\Product containing fluticasone\Product containing fluticasone in pulmonary dose form (medicinal product form)\Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing corticosteroid and/or corticosteroid derivative (product)\Product containing fluorinated corticosteroid\Product containing fluticasone\Product containing fluticasone and salmeterol\Fluticasone + Salmeterol\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing corticosteroid and/or corticosteroid derivative (product)\Product containing fluorinated corticosteroid\Product containing fluticasone\Product containing fluticasone and salmeterol\Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing corticosteroid and/or corticosteroid derivative (product)\Product containing glucocorticoid\Product containing fluticasone\Product containing fluticasone in pulmonary dose form (medicinal product form)\Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing corticosteroid and/or corticosteroid derivative (product)\Product containing glucocorticoid\Product containing fluticasone\Product containing fluticasone and salmeterol\Fluticasone + Salmeterol\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing corticosteroid and/or corticosteroid derivative (product)\Product containing glucocorticoid\Product containing fluticasone\Product containing fluticasone and salmeterol\Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing salmeterol\Product containing salmeterol in pulmonary dose form (medicinal product form)\Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing salmeterol\Product containing fluticasone and salmeterol\Fluticasone + Salmeterol\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing salmeterol\Product containing fluticasone and salmeterol\Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Product containing autonomic agent\Product containing sympathomimetic\Product containing adrenergic receptor agonist\Product containing beta adrenergic receptor agonist\Product containing beta-2 adrenergic receptor agonist\Product containing salmeterol\Product containing salmeterol in pulmonary dose form (medicinal product form)\Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Product containing autonomic agent\Product containing sympathomimetic\Product containing adrenergic receptor agonist\Product containing beta adrenergic receptor agonist\Product containing beta-2 adrenergic receptor agonist\Product containing salmeterol\Product containing fluticasone and salmeterol\Fluticasone + Salmeterol\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)
\Medicinal product\Product containing autonomic agent\Product containing sympathomimetic\Product containing adrenergic receptor agonist\Product containing beta adrenergic receptor agonist\Product containing beta-2 adrenergic receptor agonist\Product containing salmeterol\Product containing fluticasone and salmeterol\Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)\Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3699391010 Fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation en Synonym Active Entire term case insensitive SNOMED CT core module

3759885012 Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Has presentation strength denominator unit	Actuation	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Has precise active ingredient	Fluticasone propionate	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Has presentation strength numerator unit	microgram	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Has basis of strength substance	Fluticasone propionate	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Has unit of presentation	Actuation	true	Inferred relationship	Existential restriction modifier
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Is a	Product manufactured as pulmonary dose form	false	Inferred relationship	Existential restriction modifier
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Has precise active ingredient	Salmeterol xinafoate	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Has presentation strength numerator value	50	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Has presentation strength numerator unit	microgram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Has presentation strength denominator unit	Actuation	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Is a	Product containing fluticasone and salmeterol	false	Inferred relationship	Existential restriction modifier
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Has presentation strength numerator value	100	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Has basis of strength substance	Salmeterol	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Has manufactured dose form	Conventional release powder for inhalation	true	Inferred relationship	Existential restriction modifier
Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Is a	Product containing only fluticasone and salmeterol in pulmonary dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3699391010	Fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3759885012	Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module